Paid Clinical Trials in Edina, MN
As of July 2026, 118 paid clinical trials are recruiting in Edina, Minnesota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Edina offers studies at sites including Fairview Southdale Hospital for conditions such as Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Edina
Trials by drug in Edina
Filter results
Newly added in Edina
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
113 clinical trials
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Strategy for Improving Stroke Treatment Response
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Prevail Global Study
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Family Communications After Genetic Testing
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Top Research Study Locations in Edina
Researchers run research studies in Edina, MN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Fairview Southdale Hospital | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 | 81 |
| Minnesota Oncology - Edina | Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8, HER2-Negative Breast Carcinoma | 25 |
| Minnesota Oncology Hematology, P.A. | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 4 |
| M Health Fairview Southdale Hospital | Ischemic Stroke, Intracerebral Hemorrhage | 3 |
| DaVita Clinical Research Edina | Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis, Hyperphosphatemia | 2 |
| M Health Fairview Cancer Clinic-Edina | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Colorectal Neoplasms | 2 |
| Minnesota Oncology Hematology PA | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Extensive Stage Small-cell Lung Cancer | 2 |
| Nura Precision Pain Management | Degenerative Conditions of the Lumbar Spine, Fusion of Spine, Lumbar Spinal Stenosis | 2 |
| Retina Consultants of Minnesota | Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration | 2 |
| Twin Cities Orthopedics | Knee Injuries | 2 |
| Minnesota Oncology Hematology, PA | Colorectal Neoplasms, Cervical Cancer | 2 |
| AES - DRS - Synexus Clinical Research US, Inc. - Edina - Minneapolis | Type II Diabetes Mellitus | 1 |
| Allina Health System DBA Sports and Orthopaedic Specialists | Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff, Osteoarthritis of the Shoulder | 1 |
| DCR Edina | Kidney Disease | 1 |
| Fairview Health Services | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Inter Med Consultants | Immunoglobulin A Nephropathy (IgAN) | 1 |
| Investigational | Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion | 1 |
| Local Institution - 007-589A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0521 | Non-Small Cell Lung Cancer | 1 |
| M Health Fairview Clinic | Coronary Artery Disease | 1 |
| M Health Fairview Clinics and Surgery Center | Cervical Cancer | 1 |
| Retina Consultants of Minnesota (RCM) - Edina Retina Clinic | Neovascular Age-related Macular Degeneration | 1 |
| Southdale | Acute Infection, Organ Failure, Sepsis | 1 |
| Twin Cities Pain Clinic and Surgery Center | Lumbar Spinal Stenosis | 1 |
| USOR - Minnesota Oncology - Edina Clinic | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
Active & Upcoming Studies in Edina (2026)
Recruiting trials in Edina grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (82 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Eye & vision (6 active studies)
Neurology & pain (2 active studies)
- StrokeNet Thrombectomy Endovascular Platform · Medical University of South Carolina
- Strategy for Improving Stroke Treatment Response · Phase 2 · Translational Sciences, Inc.
Cardiovascular (2 active studies)
- Prevail Global Study · Medtronic Vascular
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Mental health & behavior (1 active study)
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (1 active study)
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus · Phase 2 · Corxel Pharmaceuticals
Common conditions studied in Edina
- Acute Myeloid Leukemia (6 active studies)
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Stage IIIB Lung Cancer AJCC v8 (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Stage IVB Prostate Cancer AJCC v8 (4 active studies)
Leading research sponsors in Edina
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Edina?
There are approximately 118 recruiting clinical trials in Edina, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Edina pay participants?
Most recruiting trials in Edina compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Edina?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Edina?
The most common conditions under active study in Edina include Acute Myeloid Leukemia (6), Stage IV Lung Cancer AJCC v8 (6), Stage IIIB Lung Cancer AJCC v8 (5), Anatomic Stage II Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Edina?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Edina on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Edina?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Edina?
Recruiting research sites in Edina include Fairview Southdale Hospital, Minnesota Oncology - Edina, Minnesota Oncology Hematology, P.A., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Edina right now?
The largest active categories in Edina are Cancer & tumors (82), Eye & vision (6), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.